- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.05. | Glucotrack CEO explains tech behind long-term CBGM implant | 1 | MassDevice | ||
| 15.05. | Glucotrack reports Q1 results | 1 | Seeking Alpha | ||
| 14.05. | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | 440 | GlobeNewswire (Europe) | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| 14.05. | Glucotrack, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 14.05. | Glucotrack, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 07.05. | Glucotrack submits long-term implantable CBGM for FDA IDE | - | MassDevice | ||
| 07.05. | Glucotrack beantragt FDA-Zulassung für implantierbaren Blutzuckermonitor | 4 | Investing.com Deutsch | ||
| 07.05. | Glucotrack, Inc.: Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology | 126 | GlobeNewswire (Europe) | RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization... ► Artikel lesen | |
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 30.04. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.04. | Glucotrack, Inc.: Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology | 2 | GlobeNewswire (USA) | ||
| 21.04. | Glucotrack veröffentlicht Peer-Review-Studie zur Langzeitstabilität seines Glukosesensors | 3 | Investing.com Deutsch | ||
| 14.04. | Glucotrack wandelt Schuldschein über 600.000 US-Dollar in Aktien um | 4 | Investing.com Deutsch | ||
| 14.04. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.03. | GlucoTrack, Inc.: Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights | 373 | GlobeNewswire (Europe) | Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued patents... ► Artikel lesen | |
| 30.03. | Glucotrack GAAP EPS of -$31.22 | 1 | Seeking Alpha | ||
| 30.03. | Glucotrack, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 27.03. | GlucoTrack Shares Surge 34% On FDA Submission Progress For Implantable Glucose Monitor | 2 | RTTNews | ||
| 27.03. | GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech | 1 | Benzinga.com | ||
| 27.03. | Glucotrack to submit continuous blood glucose monitor for FDA IDE in early Q2 | 1 | MassDevice | ||
| 27.03. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,470 | -1,21 % | Was Insider bei Eckert&Ziegler zum Wochenstart bereits wissen: Die Entwicklung die jetzt niemand auf dem Schirm hat - Was sich am Wochenende verändert hat! | ||
| SERNOVA BIOTHERAPEUTICS | 0,090 | -6,63 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,012 | -12,68 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,060 | 0,00 % | UniDoc Health Corp.: UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase | AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: 150.000 Aktien gekauft - das ist der Grund! | Die Aktie von Sonoma Pharmaceuticals ist Zockern aus der sharedeals.de-Community seit Jahren bekannt. Mehrfach wurden dreistellige Kurs-Peaks innerhalb kürzester Zeit für herausragend lukrative Trading-Exits... ► Artikel lesen | |
| CO-DIAGNOSTICS | 5,725 | +1,69 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUIDELORTHO | 12,155 | -2,21 % | QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk | ||
| QUEST DIAGNOSTICS | 168,90 | -2,82 % | Quest Diagnostics Raises 2026 EPS, Revenue Guidance | WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX) said, for full year 2026, the company now expects adjusted diluted EPS in a range of $10.63 $10.83, revised from prior guidance range of $10.50... ► Artikel lesen | |
| VERU | 3,410 | +0,29 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| LIFEWARD | 7,080 | +0,71 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| SENSEONICS | 5,850 | +0,86 % | Senseonics Holdings, Inc.: Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems | ||
| TEMPEST THERAPEUTICS | 1,265 | -0,39 % | Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors | BRISANE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest" or "Tempest Therapeutics") today announced the appointment of two independent directors, Drake... ► Artikel lesen |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,612 Euro und damit +0,92 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.